Ethylene Glycol and Diethylene Glycol - Live Webinar In view of the current regulation and the current Warning Letters of the FDA

Ethylene Glycol and Diethylene Glycol - Live Webinar

Course No 21287

All times mentioned are CET.


This training/webinar cannot be booked. To find alternative dates for this training/webinar or similar events please see the events list by topic.

For many training courses and webinars, there are also recordings you can order and watch any time. You can find these recordings in a list sorted by topic.

Or simply send us your inquiry by using the following contact form.

* also payable by credit card American Express Visa Mastercard

If you have any questions, please contact us:
Tel.: +49 (0)6221 / 84 44 0 E-Mail:


Alexander Doppelreiter, CEO, Head QC of Reference Analytics


In recent months, the awareness for the impurities ethylene glycol and diethylene glycol in pharmaceutical products was increased due to several warning letters issued by the FDA and a call for action by the WHO.

Ethylen glycol (EG) and diethylene glycol (DEG) are potentially harmful impurities that can be found in pharmaceutical products. The compounds are commonly used in industrial applications, such as in the production of plastics and solvents. However, their presence in pharmaceuticals is a cause for concern due to its toxic properties.

The presence of EG and DEG in pharmaceutical products can result from various sources, including improper sourcing of raw materials or cross-contamination in manufacturing equipment. Regulatory agencies around the world have set strict limits on the permissible levels of those impurities in pharmaceutical products to ensure patient safety.

Manufacturers are required to implement robust quality control practices, including thorough testing of raw materials and finished products, to detect and prevent contamination. Regular monitoring and adherence to regulatory guidelines are crucial to ensure that pharmaceutical products are free from harmful levels of these impurities, safeguarding the health of patients, who rely on these medications.

Target Group

This webinar addresses itself to all, which are involved in quality control of incoming goods, starting material or release of final drug product.
  • Analytical laboratory managers and their colleagues
  • Analytical scientists
  • QA, manufacturing and supply chain professionals

Technical Requirements

We use WebEx for our live online training courses and webinars. At you will find all the information you need to participate in our trainings and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.


This webinar will give a short overview of the impurities, possible sources and analytical strategies.
  • Content of current FDA warning letters
  • Guidance for Industry: Testing of Glycerin for Diethylene
  • Glycol and Ethylene Glycol
  • Possible sources of contamination

Go back

GMP Conferences by Topics